We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CTSH:NASDAQCognizant Technology Solutions Corporation Analysis

Data as of 2026-05-24 - not real-time

$52.75

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Cognizant is trading at $52.75, comfortably above its 20‑day SMA of 51.16 but still below the 50‑day SMA (56.66) and the 200‑day SMA (69.25), indicating short‑term momentum within a longer‑term bearish backdrop. The RSI sits at 49, suggesting neutral price pressure, while the MACD histogram is positive, giving a modest bullish signal despite a negative MACD line. Volatility remains elevated at 44% (30‑day), yet the stock’s beta of 0.64 points to lower systematic risk relative to the market. Valuation metrics are compelling: a trailing PE of 11.4x versus an industry average of 39.5x, and a DCF‑derived fair value of $68.20, implying roughly 37% upside.
Fundamentally, Cognizant delivers solid profitability with a 10.4% net margin, ROE near 15%, and a healthy cash position that exceeds its debt. The dividend yield of 2.5% is backed by a modest payout ratio of 27%, supporting sustainability. Recent corporate actions—doubling the 2026 buyback allocation to $2 billion and launching a $500 million accelerated share repurchase—signal confidence in cash generation. Additionally, the announced AI‑builder acquisition positions the firm to capture growth in high‑margin AI services.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Price near resistance at $56.23 with increasing volume
  • Positive MACD histogram despite overall bearish trend
  • Upcoming dividend ex‑date reinforcing cash return

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued valuation relative to industry and DCF fair value
  • AI acquisition expanding high‑growth service offerings
  • Robust share buyback program enhancing shareholder upside

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend yield with low payout ratio
  • Strong cash flow generation and net cash position
  • Strategic positioning in AI and digital transformation markets

Key Metrics & Analysis

Financial Health

Revenue Growth5.80%
Profit Margin10.41%
P/E Ratio11.4
ROE14.88%
ROA10.44%
Debt/Equity7.25
P/B Ratio1.7
Op. Cash Flow$2.8B
Free Cash Flow$1.9B
Industry P/E39.5

Technical Analysis

TrendBearish
RSI49.1
Support$45.48
Resistance$56.23
MA 20$51.16
MA 50$56.66
MA 200$69.25
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair Value$68.20
Target Price$72.52
Upside/Downside37.48%
GradeUndervalued
TypeBlend
Dividend Yield2.50%

Risk Assessment

Beta0.64
Volatility44.15%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.